Flublok v. Standard Dose Vaccine Effectiveness Among Kaiser Permanente Northern California Adults 18-64 Years

Conditions:   Influenza;   Pneumonia;   Lower Respiratory Tract Infection;   Acute Myocardial Infarction;   Congestive Heart Failure;   Stroke Interventions:   Biological: Flublok Quadrivalent;   Biological: Standard Dose Inactivated Influenza Vaccine (SD-IIV) Sponsors:   Kaiser Permanente;   Sanofi Pasteur, a Sanofi Company Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials